The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(5-(4-carbamimidoylphenyl)furan-2-yl)benzo[d]oxazole-5-carboximidamide ID: ALA1650566
PubChem CID: 10132304
Max Phase: Preclinical
Molecular Formula: C19H15N5O2
Molecular Weight: 345.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Synonyms: DB828 | CHEMBL1650566|SCHEMBL14519311|DB828
Canonical SMILES: N=C(N)c1ccc(-c2ccc(-c3nc4cc(C(=N)N)ccc4o3)o2)cc1
Standard InChI: InChI=1S/C19H15N5O2/c20-17(21)11-3-1-10(2-4-11)14-7-8-16(25-14)19-24-13-9-12(18(22)23)5-6-15(13)26-19/h1-9H,(H3,20,21)(H3,22,23)
Standard InChI Key: QGSDZVBDALDXMK-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
7.3465 -21.3148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3452 -22.1429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0587 -22.5562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7785 -22.1425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7754 -21.3107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0567 -20.9016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6296 -22.5547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9152 -22.1409 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6284 -23.3804 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4879 -20.8949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1566 -21.3821 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.8261 -20.8990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5736 -20.1129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7479 -20.1104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5358 -21.3102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6247 -22.1255 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2900 -20.9773 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.8380 -21.5876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4249 -22.2932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8295 -23.0016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6468 -23.0055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0580 -22.2952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6511 -21.5897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0576 -23.7217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6427 -24.4355 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8832 -23.7242 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11 12 1 0
12 13 2 0
13 14 1 0
14 10 2 0
2 7 1 0
12 15 1 0
15 16 2 0
3 4 2 0
7 8 2 0
16 19 1 0
18 17 1 0
17 15 1 0
7 9 1 0
18 19 2 0
4 5 1 0
19 20 1 0
5 10 1 0
20 21 2 0
10 11 1 0
21 22 1 0
2 3 1 0
22 23 2 0
23 18 1 0
5 6 2 0
21 24 1 0
6 1 1 0
24 25 1 0
1 2 2 0
24 26 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 345.36Molecular Weight (Monoisotopic): 345.1226AlogP: 3.32#Rotatable Bonds: 4Polar Surface Area: 138.91Molecular Species: BASEHBA: 5HBD: 4#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 6#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 11.22CX LogP: 1.81CX LogD: -2.94Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.33Np Likeness Score: -0.77
References 1. Gillingwater K, Kumar A, Anbazhagan M, Boykin DW, Tidwell RR, Brun R.. (2009) In vivo investigations of selected diamidine compounds against Trypanosoma evansi using a mouse model., 53 (12): [PMID:19786604 ] [10.1128/aac.00422-09 ] 2. Depauw S, Lambert M, Jambon S, Paul A, Peixoto P, Nhili R, Marongiu L, Figeac M, Dassi C, Paul-Constant C, Billoré B, Kumar A, Farahat AA, Ismail MA, Mineva E, Sweat DP, Stephens CE, Boykin DW, Wilson WD, David-Cordonnier MH.. (2019) Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell Model., 62 (3.0): [PMID:30645099 ] [10.1021/acs.jmedchem.8b01448 ]